What is Bacteriostatic Water?
Bacteriostatic water (BAC water) is sterile water for injection that contains 0.9% benzyl alcohol as a bacteriostatic preservative. The benzyl alcohol inhibits the growth of microorganisms, allowing the solution to be used for multiple withdrawals from a single vial over an extended period (typically up to 28 days). This multi-dose capability distinguishes BAC water from sterile water for injection (SWFI), which contains no preservative and must be used immediately after opening.
BAC water is the standard solvent for reconstituting lyophilized (freeze-dried) peptides. When a peptide is manufactured, it is freeze-dried into a stable powder to preserve its biological activity during storage and transport. Before use, this powder must be dissolved back into solution. BAC water is the preferred choice because its preservative properties extend the usable life of the reconstituted peptide from hours (with plain sterile water) to days or weeks, depending on the specific compound.
The 0.9% benzyl alcohol concentration is carefully chosen: high enough to provide effective bacteriostatic activity against common environmental contaminants, yet low enough to be well-tolerated when injected subcutaneously or intramuscularly. This concentration has been used safely in injectable medications for decades. BAC water is USP-grade (United States Pharmacopeia), meaning it meets strict pharmaceutical standards for sterility, particulate matter, and endotoxin content.
Composition & Standards
Understanding BAC water's composition helps explain why it is the preferred reconstitution solvent for peptide research.
Benzyl Alcohol (0.9% w/v)
Benzyl alcohol (C6H5CH2OH) is an aromatic alcohol used as a bacteriostatic preservative in injectable pharmaceutical formulations since the 1940s. At 0.9% concentration, it effectively inhibits the growth of bacteria, yeast, and molds without significant cytotoxic effects on mammalian cells. Its mechanism involves disruption of microbial cell membrane integrity and interference with microbial energy metabolism [1].
Water for Injection (WFI)
The base solvent meets USP standards for Water for Injection, which requires purification by distillation or equivalent processes, resulting in water free of pyrogens (fever-causing substances), particulate matter, and microbial contamination. The final product undergoes terminal sterilization (typically autoclaving at 121°C) before sealing [2].
pH and Compatibility
BAC water has a slightly acidic pH of approximately 5.7, which is compatible with the majority of research peptides. Some peptides with specific pH requirements (particularly those that aggregate at mildly acidic pH) may require alternative solvents such as acetic acid water or sodium chloride solution. Always consult the peptide's certificate of analysis for the recommended reconstitution solvent.
USP Specifications
USP-grade BAC water must meet strict specifications for sterility, bacterial endotoxin content (<0.5 EU/mL), particulate matter (sub-visible and visible), and benzyl alcohol concentration (0.9% ± 10%). These standards ensure consistency and safety across different manufacturers and production lots [1].
How to Use Bacteriostatic Water
Proper reconstitution technique is critical for maintaining peptide efficacy, accurate dosing, and injection safety.
- Alcohol-swab the top of both the BAC water vial and the peptide vial. Allow both to air dry completely (approximately 30 seconds).
- Using a sterile syringe, draw the desired volume of BAC water. The volume determines the concentration of the final solution.
- Insert the needle through the peptide vial's rubber stopper. Let the water run slowly down the inner glass wall of the vial — never spray directly onto the lyophilized powder, as this can damage the peptide's tertiary structure.
- Allow the vial to sit undisturbed for 1–2 minutes. If the peptide has not fully dissolved, gently roll the vial between your palms. Never shake vigorously — agitation can denature the peptide through shear forces and foaming.
- Verify the solution is completely clear and free of particulate matter. Most peptide solutions should be colorless (copper peptides are an exception — expect a blue-green tint). Discard any solution that appears cloudy or contains visible particles.
Vigorous shaking creates air-liquid interfaces and foam that can denature peptides through mechanical stress on the protein structure. If the peptide does not dissolve within 5 minutes of gentle rolling, allow it to sit at room temperature for 15–30 minutes. If it still does not dissolve, the peptide may require a different solvent (such as acetic acid water) or may be degraded.
Reconstitution Calculator
Use these formulas to calculate peptide concentration and injection volume for any vial size.
Concentration formula: Peptide amount (mg) ÷ BAC water volume (mL) = concentration (mg/mL)
Dose calculation: Desired dose (mcg) ÷ concentration (mcg/mL) = injection volume (mL)
Syringe units: Injection volume (mL) × 100 = units on a 100-unit insulin syringe
| Peptide Vial | BAC Water Added | Concentration | 250 mcg = | 500 mcg = |
|---|---|---|---|---|
| 5 mg | 1 mL | 5,000 mcg/mL | 5 units (0.05 mL) | 10 units (0.1 mL) |
| 5 mg | 2 mL | 2,500 mcg/mL | 10 units (0.1 mL) | 20 units (0.2 mL) |
| 10 mg | 2 mL | 5,000 mcg/mL | 5 units (0.05 mL) | 10 units (0.1 mL) |
| 10 mg | 3 mL | 3,333 mcg/mL | 7.5 units (0.075 mL) | 15 units (0.15 mL) |
- Higher concentration (less water): Smaller injection volumes per dose, fewer units to draw. Better for peptides dosed at high mcg amounts or when you want to minimize injection volume.
- Lower concentration (more water): Easier to measure small doses accurately. Better for peptides dosed at low mcg amounts (e.g., 100 mcg) where precision matters.
- A common rule of thumb: choose a volume where your most frequent dose equals 5–20 units on an insulin syringe for easy, accurate measurement.
Sterile Technique Essentials
While BAC water's preservative provides ongoing protection against microbial growth, proper sterile technique during each withdrawal minimizes contamination risk and ensures the 28-day multi-use window remains safe.
- Wash hands thoroughly with soap and water before handling any vials or syringes. Dry with a clean towel or air dry.
- Alcohol-swab vial tops before every single withdrawal — not just the first time. Use a fresh prep pad each time and allow the alcohol to air dry completely.
- Use a new, sterile syringe and needle for each reconstitution and each injection. Never reuse needles or syringes, even for the same vial.
- Work on a clean, flat surface. Avoid reconstituting near sinks, open windows, or areas with airborne contaminants.
Never use the same syringe to draw from a BAC water vial and then a different peptide vial. Never draw from two different peptide vials with the same syringe. Each reconstitution event should use a fresh syringe to prevent cross-contamination between products.
Storage & Shelf Life
BAC water has relatively flexible storage requirements compared to the peptides it reconstitutes.
- BAC water can be stored at room temperature — it does not need refrigeration (unlike reconstituted peptide solutions).
- Once a peptide is reconstituted WITH BAC water, the reconstituted peptide vial should be refrigerated. The BAC water vial itself stays at room temperature.
- Mark the date of first puncture on each BAC water vial. Discard after 28 days regardless of remaining volume.
- The 10 mL vials are more economical for researchers using multiple peptide vials. The 3 mL vials are convenient for single-peptide protocols.
Safety Considerations
BAC water has an extensive safety record spanning decades of use in injectable pharmaceutical products. However, specific populations and situations require awareness.
General Safety
- Well-tolerated for subcutaneous and intramuscular injection in adults.
- The 0.9% benzyl alcohol concentration is far below levels associated with toxicity in adults.
- Mild stinging at the injection site is occasionally reported and is attributed to the benzyl alcohol. This is normal and transient.
Contraindications & Precautions
- Neonates and infants: Do NOT use BAC water for neonates or infants. Benzyl alcohol has been associated with fatal "gasping syndrome" in premature neonates. Use plain sterile water for injection (SWFI) instead [3].
- Benzyl alcohol allergy: Individuals with a known allergy to benzyl alcohol should use plain sterile water for injection (single-use only, no preservative).
- Large-volume injections: BAC water should not be used for large-volume IV infusions. The benzyl alcohol dose must not exceed 5 mg/kg/day for repeated injections.
- Never mix two different peptides in the same BAC water vial.
If you cannot use BAC water (allergy, specific peptide incompatibility), plain SWFI is the alternative. However, SWFI contains no preservative and must be used immediately after vial puncture — it is single-use only. Any remaining SWFI must be discarded. This makes SWFI impractical for multi-day peptide protocols, which is why BAC water is strongly preferred.
BAC Water vs. Other Solvents
Different peptides may require different reconstitution solvents. Understanding when to use each type prevents compatibility issues.
| Solvent | Preservative | Multi-dose | Best For | Avoid When |
|---|---|---|---|---|
| Bacteriostatic Water | 0.9% benzyl alcohol | Yes (28 days) | Most peptides (BPC-157, TB-500, CJC/Ipa, etc.) | Neonates, benzyl alcohol allergy |
| Sterile Water (SWFI) | None | No (single use) | When BAC water is contraindicated | Multi-day protocols |
| Acetic Acid Water | None (acidic pH) | 28 days | Peptides requiring acidic pH for solubility | Peptides stable at neutral pH |
| Normal Saline (0.9%) | None | No (single use) | Dilution, IV applications | Standard SubQ peptide protocols |
Bacteriostatic water is available in 10 mL and 3 mL vials from Heritage Labs USA, a U.S.-based research supplier with pharmaceutical-grade products.
- USP-grade bacteriostatic water
- U.S.-based fulfillment
- Available in 3 mL and 10 mL vials
Literature & Citations
- United States Pharmacopeia. Bacteriostatic Water for Injection, USP. USP-NF. Current edition. USP
- WHO Expert Committee on Specifications for Pharmaceutical Preparations. Good manufacturing practices for sterile pharmaceutical products. WHO Technical Report Series. No. 961, 2011. WHO
- Nema S, Brendel RJ. Excipient Interaction and Incompatibility Studies in Injectable Pharmaceutical Formulations. PDA J Pharm Sci Technol. 2011;65(6):624-636. PubMed
- American Academy of Pediatrics Committee on Drugs. "Inactive" ingredients in pharmaceutical products: update. Pediatrics. 1997;99(2):268-278. PubMed
- Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185(2):129-188. PubMed